A detailed history of Mba Advisors LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Mba Advisors LLC holds 5,552 shares of JNJ stock, worth $809,759. This represents 0.43% of its overall portfolio holdings.

Number of Shares
5,552
Previous 5,469 1.52%
Holding current value
$809,759
Previous $799,000 12.52%
% of portfolio
0.43%
Previous 0.41%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$145.48 - $167.38 $12,074 - $13,892
83 Added 1.52%
5,552 $899,000
Q2 2024

Jul 30, 2024

SELL
$144.38 - $157.78 $63,815 - $69,738
-442 Reduced 7.48%
5,469 $799,000
Q1 2024

Apr 26, 2024

BUY
$155.22 - $162.74 $23,748 - $24,899
153 Added 2.66%
5,911 $935,000
Q4 2023

Jan 19, 2024

SELL
$145.6 - $158.88 $105,705 - $115,346
-726 Reduced 11.2%
5,758 $902,000
Q3 2023

Oct 19, 2023

SELL
$155.75 - $174.48 $5,607 - $6,281
-36 Reduced 0.55%
6,484 $1.01 Million
Q2 2023

Jul 21, 2023

SELL
$154.35 - $166.11 $33,648 - $36,211
-218 Reduced 3.24%
6,520 $1.08 Million
Q1 2023

Apr 20, 2023

BUY
$151.05 - $180.26 $2,416 - $2,884
16 Added 0.24%
6,738 $1.04 Million
Q4 2022

Jan 25, 2023

BUY
$160.2 - $179.79 $71,449 - $80,186
446 Added 7.11%
6,722 $0
Q3 2022

Oct 31, 2022

SELL
$161.33 - $179.52 $55,013 - $61,216
-341 Reduced 5.15%
6,276 $1.03 Million
Q2 2022

Aug 08, 2022

SELL
$168.19 - $186.01 $5,382 - $5,952
-32 Reduced 0.48%
6,617 $1.17 Million
Q1 2022

May 16, 2022

BUY
$158.14 - $179.59 $5,218 - $5,926
33 Added 0.5%
6,649 $1.18 Million
Q4 2021

Feb 11, 2022

BUY
$155.93 - $173.01 $20,270 - $22,491
130 Added 2.0%
6,616 $1.13 Million
Q3 2021

Nov 16, 2021

SELL
$161.5 - $179.47 $2,422 - $2,692
-15 Reduced 0.23%
6,486 $1.05 Million
Q2 2021

Aug 16, 2021

BUY
$159.48 - $171.07 $2,073 - $2,223
13 Added 0.2%
6,501 $1.07 Million
Q1 2021

May 18, 2021

BUY
$153.07 - $170.48 $993,118 - $1.11 Million
6,488 New
6,488 $1.07 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Mba Advisors LLC Portfolio

Follow Mba Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mba Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mba Advisors LLC with notifications on news.